APA (7th ed.) Citation

D, M., PC, R., T, B., GA, P., JR, H., K, G., . . . HIM, B. (2018). 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization. ACS infectious diseases, 4(6), 954. https://doi.org/10.1021/acsinfecdis.7b00275

Chicago Style (17th ed.) Citation

D, Murugesan, et al. "2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium Tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization." ACS Infectious Diseases 4, no. 6 (2018): 954. https://doi.org/10.1021/acsinfecdis.7b00275.

MLA (9th ed.) Citation

D, Murugesan, et al. "2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium Tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization." ACS Infectious Diseases, vol. 4, no. 6, 2018, p. 954, https://doi.org/10.1021/acsinfecdis.7b00275.